Biopsy was performed and confirmed adenocarcinoma.
Endoscopic U/S was performed in [**1-/2111**] and noted a 4.0 x 4.2-cm ill-defined mass in the peri-ampullary region which was heterogeneous and hypoechoic.
He underwent a diagnostic laparoscopy and elective pancreaticoduodenectomy (Whipple procedure) with pylorus preservation on [**2111-2-11**] with Dr. [**First Name8 (NamePattern2) 402**] [**Last Name (NamePattern1) **].
Final pathology noted T2 N1 stage IIB adenocarcinoma of the ampulla.
In the [**Hospital1 18**] ED, initial VS 104.6 119 109/69 22 97% RA.
Exam notable for marked scleral icterus and jaundice.
Laboratory data notable for WBC 8.0, hematocrit 37.8%, platelets 205.
LFTs: AST 87, ALT 223, AP 427, T-bili 6.4 and direct bili 4.6.
Creatinine 0.8.
A CT scan of the abdomen showed no intra- or extrahepatic bile duct dilatation and no abscess, but no PO contrast was given.
RESP: Clear to auscultation bilaterally without adventitious sounds.
DTRs 2+ throughout, strength 5/5 bilaterally, sensation grossly intact.
A stiffening wire was used and the duodenoscope was able to move nearly to the area of fluoroscopically-noted hemoclips, but the limb was too long to completely navigate with a duodenoscope.
Blood cultures grew gram positive cocci, he was started on vancomycin.
Speciation of the blood cultures revealed enterococci sensitive to Linezolid.
# CHRONIC NORMOCYTIC ANEMIA - Chronic normocytic anemia with hematocrit in the 36-37% range at baseline without prior iron studies.
Please follow up with your primary care physician (Dr. [**First Name8 (NamePattern2) **] [**Last Name (NamePattern1) 1169**], Address: [**Doctor Last Name 40418**], [**Location (un) **],[**Numeric Identifier 62441**] Phone: [**Telephone/Fax (1) 40420**]), weekly while taking Linezolid to monitor your liver function tests; two appointments have been made for you to follow-up at Dr.[**Name (NI) 91912**] office to have the liver function tests performed: [**2111-8-13**] and [**2111-8-20**].
